Raster-scanned carbon ion therapy for malignant salivary gland tumors: acute toxicity and initial treatment response (Q39322631)

11 September 2017

Raster-scanned carbon ion therapy for malignant salivary gland tumors: acute toxicity and initial treatment response (English)

1 reference

11 September 2017

5

Jürgen Debus

1 reference

11 September 2017

Alexandra D Jensen

1

1 reference

11 September 2017

Anna V Nikoghosyan

2

1 reference

11 September 2017

Swantje Ecker

3

1 reference

11 September 2017

Malte Ellerbrock

4

1 reference

11 September 2017

Klaus K Herfarth

6

1 reference

11 September 2017

Marc W Münter

7

1 reference

11 September 2017

2 November 2011

1 reference

11 September 2017

1 reference

11 September 2017

6

1 reference

11 September 2017

149

1 reference

Creative Commons Attribution 2.0 Generic

11 September 2017

start time

2 November 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

exact match

https://scigraph.springernature.com/pub.10.1186/1748-717x-6-149

0 references

cites work

Combined treatment of adenoid cystic carcinoma with cetuximab and IMRT plus C12 heavy ion boost: ACCEPT [ACC, Erbitux® and particle therapy].

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3222621

RadioImmunotherapy for adenoid cystic carcinoma: a single-institution series of combined treatment with cetuximab

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3222621

Combined treatment of malignant salivary gland tumours with intensity-modulated radiation therapy (IMRT) and carbon ions: COSMIC.

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3222621

Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3222621

Outcomes of postoperative concurrent chemoradiotherapy for locally advanced major salivary gland carcinoma

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3222621

Salvage re-irradiation for recurrent head and neck cancer

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3222621

Adenoid cystic carcinoma of the head and neck treated by surgery with or without postoperative radiation therapy: prognostic features of recurrence

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3222621

Inverse planned stereotactic intensity modulated radiotherapy (IMRT) in the treatment of incompletely and completely resected adenoid cystic carcinomas of the head and neck: initial clinical results and toxicity of treatment

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3222621

Chemoradiotherapy for adenoid cystic carcinoma: preliminary results of an organ sparing approach

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3222621

Adenoid cystic carcinoma of the major salivary glands treated with surgery and radiation

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3222621

Therapy strategies for locally advanced adenoid cystic carcinomas using modern radiation therapy techniques

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3222621

The role of radiotherapy in the treatment of malignant salivary gland tumors

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3222621

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3222621

Full-dose reirradiation for unresectable head and neck carcinoma: experience at the Gustave-Roussy Institute in a series of 169 patients

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3222621

Chemoreirradiation for recurrent salivary gland malignancies

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3222621

Meta-Analyses of Chemotherapy in Head and Neck Cancer (MACH-NC): an update.

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3222621

Local-regional recurrence after surgery without postoperative irradiation for carcinomas of the major salivary glands: implications for adjuvant therapy

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3222621

Salivary gland carcinoma: independent prognostic factors for locoregional control, distant metastases, and overall survival: results of the Dutch head and neck oncology cooperative group

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3222621

Postoperative radiation therapy for malignant tumors of minor salivary glands. Outcome and patterns of failure.

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3222621

Feasibility and toxicity of combined photon and carbon ion radiotherapy for locally advanced adenoid cystic carcinomas

21 August 2018

1 reference

12 December 2020

Treatment of salivary gland neoplasms with fast neutron radiotherapy

1 reference

12 December 2020

Radiotherapy alone or combined with surgery for adenoid cystic carcinoma of the head and neck

1 reference

12 December 2020

Dose escalation study of carbon ion radiotherapy for locally advanced head-and-neck cancer

1 reference

12 December 2020

Salivary neoplasms: overview of a 35-year experience with 2,807 patients

1 reference

12 December 2020

Proton beam radiation therapy for skull base adenoid cystic carcinoma

1 reference

12 December 2020

Fractionated stereotactic radiotherapy as reirradiation for locally recurrent head and neck cancer

1 reference

12 December 2020

Radiotherapy for advanced adenoid cystic carcinoma: neutrons, photons or mixed beam?

1 reference

12 December 2020

Identifiers

DOI

10.1186/1748-717X-6-149

1 reference

Dimensions Publication ID

11 September 2017

0 references

1 reference

11 September 2017

1 reference